When the same treatment has different response: The role of pharmacogenomics in statin therapy
Open Access
- 6 December 2023
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 170, 115966
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug‐induced liver injuryLiver International, 2013
- A Genome‐Wide Association Study for Serum Bilirubin Levels and Gene‐Environment Interaction in a Chinese PopulationGenetic Epidemiology, 2013
- Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection StudyEuropean Heart Journal, 2012
- Pharmacogenetics of OATP Transporters Reveals That SLCO1B1 c.388A>G Variant Is Determinant of Increased Atorvastatin ResponseInternational Journal of Molecular Sciences, 2011
- Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificityPharmacogenetics and Genomics, 2011
- Hepatic Metabolism and Transporter Gene Variants Enhance Response to Rosuvastatin in Patients With Acute Myocardial InfarctionCirculation: Cardiovascular Genetics, 2010
- Impact of OATP transporters on pharmacokineticsBritish Journal of Pharmacology, 2009
- Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor responsePharmacogenetics and Genomics, 2009
- Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and PravastatinClinical Pharmacokinetics, 2008
- Lipid-lowering response to statins is affected by CYP3A5 polymorphismPharmacogenetics, 2004